Suppr超能文献

实施干预措施以改善中低收入国家合理使用抗生素的障碍和促进因素:基于实施研究综合框架的系统评价。

Barriers and facilitators of implementing interventions to improve appropriate antibiotic use in low- and middle-income countries: a systematic review based on the Consolidated Framework for Implementation Research.

机构信息

Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.

Faculty of Health Sciences, Department of Clinical Biochemistry and Pharmacology, Ben Gurion University of the Negev, Beer-Sheva, Israel.

出版信息

Implement Sci. 2022 May 12;17(1):30. doi: 10.1186/s13012-022-01209-4.

Abstract

BACKGROUND

Behavior change interventions that aim to improve rational antibiotic use in prescribers and users have been widely conducted in both high- and LMICs. However, currently, no review has systematically examined challenges unique to LMICs and offered insights into the underlying contextual factors that influence these interventions. We adopted an implementation research perspective to systematically synthesize the implementation barriers and facilitators in LMICs.

METHODS

We conducted literature searches in five electronic databases and identified studies that involved the implementation of behavior change interventions to improve appropriate antibiotic use in prescribers and users in LMICs and reported implementation barriers and facilitators. Behavior change interventions were defined using the behavior change wheel, and the coding and synthesis of barriers and facilitators were guided by the Consolidated Framework for Implementation Research (CFIR).

RESULTS

We identified 52 eligible studies, with the majority targeting prescribers practicing at tertiary facilities (N=39, 75%). The most commonly reported factors influencing implementation were found in the inner setting domain of the CFIR framework, particularly related to constraints in resources and the infrastructure of the facilities where interventions were implemented. Barriers related to the external policy environment (e.g., lack of national initiatives and policies on antibiotic use), and individual characteristics of target populations (e.g., reluctance to change prescribing behaviors) were also common, as well as facilitators related to intervention characteristics (e.g., embedding interventions in routine practice) and process (e.g., stakeholder engagement). We also provided insights into the interrelationships between these factors and the underlying causes contributing to the implementation challenges in LMICs.

CONCLUSION

We presented a comprehensive overview of the barriers and facilitators of implementing behavior change interventions to promote rational antibiotic use in LMICs. Our findings suggest that facilitating the implementation of interventions to improve rational antibiotic use needs comprehensive efforts to address challenges at policy, organizational, and implementation levels. Specific strategies include (1) strengthening political commitment to prompt mobilization of domestic resources and formulation of a sustainable national strategy on AMR, (2) improving the infrastructure of health facilities that allow prescribers to make evidence-based clinical decisions, and (3) engaging local stakeholders to improve their buy-in and facilitate contextualizing interventions.

TRIAL REGISTRATION

PROSPERO: CRD42021252715 .

摘要

背景

旨在提高开方者和使用者合理使用抗生素的行为改变干预措施在高收入和中低收入国家都得到了广泛的开展。然而,目前还没有综述系统地检查中低收入国家特有的挑战,并深入了解影响这些干预措施的潜在背景因素。我们采用实施研究的视角,系统地综合了中低收入国家实施这些干预措施所面临的障碍和促进因素。

方法

我们在五个电子数据库中进行了文献检索,确定了涉及在中低收入国家实施行为改变干预措施以改善开方者和使用者合理使用抗生素的研究,并报告了实施障碍和促进因素。行为改变干预措施是使用行为改变车轮来定义的,障碍和促进因素的编码和综合是由实施研究综合框架(CFIR)指导的。

结果

我们确定了 52 项符合条件的研究,其中大多数针对在三级医疗机构行医的开方者(N=39,75%)。影响实施的最常报告因素是 CFIR 框架中的内部环境领域,特别是与干预实施的设施的资源和基础设施的限制有关。与外部政策环境有关的障碍(例如,缺乏关于抗生素使用的国家倡议和政策),以及目标人群的个体特征(例如,不愿意改变开处方行为)也很常见,与干预措施特征有关的促进因素(例如,将干预措施嵌入常规实践)和过程(例如,利益相关者参与)也是如此。我们还提供了对这些因素之间的相互关系以及导致中低收入国家实施挑战的根本原因的深入了解。

结论

我们全面介绍了在中低收入国家实施行为改变干预措施以促进合理使用抗生素的障碍和促进因素。我们的研究结果表明,促进合理使用抗生素的干预措施的实施需要全面努力来解决政策、组织和实施层面的挑战。具体策略包括(1)加强政治承诺,以迅速动员国内资源并制定可持续的国家抗微生物药物耐药性战略,(2)改善允许开方者做出基于证据的临床决策的卫生设施的基础设施,以及(3)让当地利益相关者参与进来,以提高他们的参与度并促进干预措施的本地化。

试验注册

PROSPERO:CRD42021252715。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验